Vanguard Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,932,683
| Closed | -$29M | – | 4136 |
|
|
2016
Q2 | $29M | Buy |
1,932,683
+6,913
| +0.4% | +$104K | ﹤0.01% | 2163 |
|
|
2016
Q1 | $23.4M | Buy |
1,925,770
+169,095
| +10% | +$2.06M | ﹤0.01% | 2229 |
|
|
2015
Q4 | $27.9M | Buy |
1,756,675
+58,822
| +3% | +$936K | ﹤0.01% | 2154 |
|
|
2015
Q3 | $26M | Buy |
1,697,853
+15,921
| +0.9% | +$244K | ﹤0.01% | 2172 |
|
|
2015
Q2 | $40.9M | Sell |
1,681,932
-7,263
| -0.4% | -$177K | ﹤0.01% | 2042 |
|
|
2015
Q1 | $39.3M | Buy |
1,689,195
+87,468
| +5% | +$2.03M | ﹤0.01% | 2027 |
|
|
2014
Q4 | $40.2M | Buy |
1,601,727
+117,226
| +8% | +$2.94M | ﹤0.01% | 1947 |
|
|
2014
Q3 | $46.2M | Buy |
1,484,501
+194,579
| +15% | +$6.05M | ﹤0.01% | 1837 |
|
|
2014
Q2 | $33.4M | Buy |
1,289,922
+11,557
| +0.9% | +$299K | ﹤0.01% | 2027 |
|
|
2014
Q1 | $29.9M | Buy |
1,278,365
+106,726
| +9% | +$2.49M | ﹤0.01% | 2050 |
|
|
2013
Q4 | $29.7M | Buy |
1,171,639
+100,947
| +9% | +$2.56M | ﹤0.01% | 2021 |
|
|
2013
Q3 | $21.8M | Buy |
1,070,692
+390,219
| +57% | +$7.96M | ﹤0.01% | 2076 |
|
|
2013
Q2 | $14.3M | Buy |
+680,473
| New | +$14.3M | ﹤0.01% | 2186 |
|